Marzi I, Takei Y, Rücker M, Kawano S, Fusamoto H, Walcher F, Kamada T
Department of Surgery, University of Saarland, Homburg/Saar, Germany.
Transpl Int. 1994;7 Suppl 1:S503-6. doi: 10.1111/j.1432-2277.1994.tb01430.x.
Endothelin-1 (ET-1), a vasoactive peptide, causes a significant rise in portal vein pressure, which is most likely a result of severe vasoconstriction in the liver. In this study, the effect of ET-1 on sinusoidal vasoconstriction in the liver after ischemia and reperfusion was directly investigated using intravital microscopy. In anesthetized female Sprague Dawley rats (200-250 g) ischemia of the median and left liver lobes was induced for 90 min by temporary ligation of the left pedicle. After declamping and a 90-min reperfusion period, the livers were exposed for intravital microscopy. Using a Nikon MM-11 fluorescence microscope (545 nm, 330x), a CCD camera (Cohu FK 6990), and a SVHS video recording unit, the hepatic microcirculation was directly investigated. Besides sham groups, two ischemia groups were studied, receiving ET-1 antiserum (anti-ET-1; 0.5 ml; Peptide Inst., Osaka, Japan) or NaCl 0.9% (0.5 ml) 5 min prior to reperfusion of the liver (n = 6/group). Following a transient drop in the mean arterial blood pressure in the anti-ET-1-treated groups, comparable systemic hemodynamic conditions among the four groups were noted during intravital microscopic assessment at the end of the 90-min reperfusion period. Reduction in the sinusoidal diameters during postischemic reperfusion (7.7 +/- 0.5 microm) was prevented by anti-ET-1 treatment (9.6 +/- 0.25 microm; P < 0.01; mean + SEM) back to control values (9.6 +/- 0.32 microm), while most of other microcirculatory parameters did not show significant differences. The results supported further the role of ET-1 in dysregulation of the sinusoidal vascular tone in the liver, e.g., after ischemia and reperfusion.
内皮素-1(ET-1)是一种血管活性肽,可导致门静脉压力显著升高,这很可能是肝脏严重血管收缩的结果。在本研究中,使用活体显微镜直接研究了ET-1对肝脏缺血再灌注后肝血窦血管收缩的影响。在麻醉的雌性Sprague Dawley大鼠(200 - 250 g)中,通过暂时结扎左肝蒂诱导中叶和左肝叶缺血90分钟。松开夹闭并经过90分钟的再灌注期后,暴露肝脏进行活体显微镜检查。使用尼康MM - 11荧光显微镜(545 nm,330x)、电荷耦合器件(CCD)相机(科胡FK 6990)和超级 VHS 视频记录单元,直接研究肝脏微循环。除假手术组外,研究了两个缺血组,在肝脏再灌注前5分钟分别给予ET-1抗血清(抗ET-1;0.5 ml;日本大阪肽研究所)或0.9%氯化钠(0.5 ml)(每组n = 6)。在抗ET-1治疗组平均动脉血压短暂下降后,在90分钟再灌注期末的活体显微镜评估期间,注意到四组之间的全身血流动力学状况相当。抗ET-1治疗可防止缺血后再灌注期间肝血窦直径减小(7.7±0.5微米),使其恢复到对照值(9.6±0.32微米)(9.6±0.25微米;P < 0.01;平均值±标准误),而大多数其他微循环参数未显示出显著差异。这些结果进一步支持了ET-1在肝脏血窦血管张力失调中的作用,例如在缺血再灌注后。